{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["activation of macrophages", "drug association", "leishmaniasis", "phenolic compounds", "poloxamer"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32928735", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "17"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["e00807-20", "10.1128/AAC.00807-20"], "Journal": {"ISSN": "1098-6596", "JournalIssue": {"Volume": "64", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "17"}}, "Title": "Antimicrobial agents and chemotherapy", "ISOAbbreviation": "Antimicrob Agents Chemother"}, "ArticleTitle": "Gallic and Ellagic Acids Are Promising Adjuvants to Conventional Amphotericin B for the Treatment of Cutaneous Leishmaniasis.", "Abstract": {"AbstractText": ["In this study, we demonstrated the potential associative effect of combining conventional amphotericin B (Amph B) with gallic acid (GA) and with ellagic acid (EA) in topical formulations for the treatment of cutaneous leishmaniasis in BALB/c mice. Preliminary stability tests of the formulations and <i>in vitro</i> drug release studies with Amph B, GA, Amph B plus GA, EA, and Amph B plus EA were carried out, as well as assessment of the <i>in vivo</i> treatment of BALB/c mice infected with <i>Leishmania major</i> After 40\u2009days of infection, the animals were divided into 6 groups and treated twice a day for 21\u2009days with a gel containing Amph B, GA, Amph B plus GA, EA, or Amph B plus EA, and the negative-control group was treated with the vehicle. In the animals that received treatment, there was reduction of the lesion size and reduction of the parasitic load. Histopathological analysis of the treatments with GA, EA, and combinations with Amph B showed circumscribed lesions with the presence of fibroblasts, granulation tissue, and collagen deposition, as well as the presence of activated macrophages. The formulations containing GA and EA activated macrophages in all evaluated parameters, resulting in the activation of cells of the innate immune response, which can generate healing and protection. GA and EA produced an associative effect with Amph B, which makes them promising for use with conventional Amph B in the treatment of cutaneous leishmaniasis."], "CopyrightInformation": "Copyright \u00a9 2020 American Society for Microbiology."}, "AuthorList": [{"Identifier": ["0000-0003-4541-6096"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antileishmanial Activity Laboratory, Medicinal Plants Research Center, Federal University of Piaui, Teresina, Piau\u00ed, Brazil mualemmichel@ufpi.edu.br."}, {"Identifier": [], "Affiliation": "Department of Veterinary Morphophysiology, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Alves", "ForeName": "Michel Mu\u00e1lem de Moraes", "Initials": "MMM"}, {"Identifier": ["0000-0001-7021-2744"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antileishmanial Activity Laboratory, Medicinal Plants Research Center, Federal University of Piaui, Teresina, Piau\u00ed, Brazil."}], "LastName": "Arcanjo", "ForeName": "Daniel Dias Rufino", "Initials": "DDR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antileishmanial Activity Laboratory, Medicinal Plants Research Center, Federal University of Piaui, Teresina, Piau\u00ed, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Dermopharmacy, Faculty of Pharmacy, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Figueiredo", "ForeName": "Kayo Alves", "Initials": "KA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products, Department of Chemistry, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Oliveira", "ForeName": "J\u00e9ssica Sara de Sousa Mac\u00eado", "Initials": "JSSM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Histotechnical Laboratory, Department of Morphology, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Viana", "ForeName": "Felipe Jos\u00e9 Costa", "Initials": "FJC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Dermopharmacy, Faculty of Pharmacy, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Coelho", "ForeName": "Elvilene de Sousa", "Initials": "ES"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Dermopharmacy, Faculty of Pharmacy, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Lopes", "ForeName": "Glaucia Lais Nunes", "Initials": "GLN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antileishmanial Activity Laboratory, Medicinal Plants Research Center, Federal University of Piaui, Teresina, Piau\u00ed, Brazil."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa, Para\u00edba, Brazil."}], "LastName": "Gon\u00e7alves", "ForeName": "Juan Carlos Ramos", "Initials": "JCR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Dermopharmacy, Faculty of Pharmacy, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Carvalho", "ForeName": "Andr\u00e9 Lu\u00eds Menezes", "Initials": "ALM"}, {"Identifier": ["0000-0003-4276-3113"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Histotechnical Laboratory, Department of Morphology, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Rizzo", "ForeName": "M\u00e1rcia Dos Santos", "Initials": "MDS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Natural Products, Department of Chemistry, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Chaves", "ForeName": "Mariana Helena", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Veterinary Clinics and Surgery, Federal University of Piau\u00ed, Teresina, Piau\u00ed, Brazil."}], "LastName": "Mendon\u00e7a", "ForeName": "Ivete Lopes de", "Initials": "IL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antileishmanial Activity Laboratory, Medicinal Plants Research Center, Federal University of Piaui, Teresina, Piau\u00ed, Brazil."}], "LastName": "Carvalho", "ForeName": "Fernando A\u00e9cio de Amorim", "Initials": "FAA"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Antimicrob Agents Chemother", "NlmUniqueID": "0315061", "ISSNLinking": "0066-4804"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiprotozoal Agents"}, {"RegistryNumber": "19YRN3ZS9P", "NameOfSubstance": "Ellagic Acid"}, {"RegistryNumber": "7XU7A7DROE", "NameOfSubstance": "Amphotericin B"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Amphotericin B"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiprotozoal Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ellagic Acid"}, {"QualifierName": [], "DescriptorName": "Leishmania major"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Leishmaniasis, Cutaneous"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. doi:10.1371/journal.pone.0035671.", "ArticleIdList": ["10.1371/journal.pone.0035671", "PMC3365071", "22693548"]}, {"Citation": "Akhlagh A, Salehzadeh A, Zahirnia AH, Davari B. 2019. 10-year trends in epidemiology, diagnosis, and treatment of cutaneous leishmaniasis in Hamadan Province, West of Iran (2007\u20132016). Front Public Health 7:27. doi:10.3389/fpubh.2019.00027.", "ArticleIdList": ["10.3389/fpubh.2019.00027", "PMC6413056", "30891438"]}, {"Citation": "den Boer M, Argaw D, Jannin J, Alvar J. 2011. Leishmaniasis impact and treatment access. Clin Microbiol Infect 17:1471\u20131477. doi:10.1111/j.1469-0691.2011.03635.x.", "ArticleIdList": ["10.1111/j.1469-0691.2011.03635.x", "21933305"]}, {"Citation": "Desjeux P. 2004. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305\u2013318. doi:10.1016/j.cimid.2004.03.004.", "ArticleIdList": ["10.1016/j.cimid.2004.03.004", "15225981"]}, {"Citation": "Harhay MO, Olliaro PL, Costa DL, Costa CH. 2011. Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol 27:403\u2013409. doi:10.1016/j.pt.2011.04.001.", "ArticleIdList": ["10.1016/j.pt.2011.04.001", "21596622"]}, {"Citation": "Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7:581\u2013596. doi:10.1016/S1473-3099(07)70209-8.", "ArticleIdList": ["10.1016/S1473-3099(07)70209-8", "17714672"]}, {"Citation": "Kaye P, Scott P. 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9:604\u2013615. doi:10.1038/nrmicro2608.", "ArticleIdList": ["10.1038/nrmicro2608", "21747391"]}, {"Citation": "Mitropoulos P, Konidas P, Durkin-Konidas M. 2010. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol 63:309\u2013322. doi:10.1016/j.jaad.2009.06.088.", "ArticleIdList": ["10.1016/j.jaad.2009.06.088", "20303613"]}, {"Citation": "Ashford RW. 2000. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 30:1269\u20131281. doi:10.1016/s0020-7519(00)00136-3.", "ArticleIdList": ["10.1016/s0020-7519(00)00136-3", "11113254"]}, {"Citation": "Sundar S, Singh A. 2016. Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther Adv Infect Dis 3:98\u2013109. doi:10.1177/2049936116646063.", "ArticleIdList": ["10.1177/2049936116646063", "PMC4971590", "27536354"]}, {"Citation": "Alves MMM, Brito LM, Souza AC, Queiroz B, de Carvalho TP, Batista JF, Oliveira J, de Mendonca IL, Lira SRS, Chaves MH, Goncalves JCR, Carneiro SMP, Arcanjo DDR, Carvalho FAA. 2017. Gallic and ellagic acids: two natural immunomodulator compounds solve infection of macrophages by Leishmania major. Naunyn Schmiedebergs Arch Pharmacol 390:893\u2013903. doi:10.1007/s00210-017-1387-y.", "ArticleIdList": ["10.1007/s00210-017-1387-y", "28643086"]}, {"Citation": "de Castro Oliveira LG, Brito LM, de Moraes Alves MM, Amorim LV, Sobrinho-Junior EP, de Carvalho CE, da Franca Rodrigues KA, Arcanjo DD, das Gracas Lopes Cito AM, de Amorim Carvalho FA. 2017. In vitro effects of the neolignan 2,3-dihydrobenzofuran against Leishmania amazonensis. Basic Clin Pharmacol Toxicol 120:52\u201358. doi:10.1111/bcpt.12639.", "ArticleIdList": ["10.1111/bcpt.12639", "27398818"]}, {"Citation": "Souza AC, Alves MMM, Brito LM, Oliveira LGC, Sobrinho-Junior EPC, Costa ICG, Freitas SDL, Rodrigues K, Chaves MH, Arcanjo DDR, Carvalho FAA. 2017. Platonia insignis Mart., a Brazilian Amazonian plant: the stem barks extract and its main constituent lupeol exert antileishmanial effects involving macrophages activation. Evid Based Complement Alternat Med 2017:3126458. doi:10.1155/2017/3126458.", "ArticleIdList": ["10.1155/2017/3126458", "PMC5567447", "28852412"]}, {"Citation": "Cunha MA, Leao AC, de Cassia Soler R, Lindoso JA. 2015. Efficacy and safety of liposomal amphotericin B for the treatment of mucosal leishmaniasis from the New World: a retrospective study. Am J Trop Med Hyg 93:1214\u20131218. doi:10.4269/ajtmh.15-0033.", "ArticleIdList": ["10.4269/ajtmh.15-0033", "PMC4674237", "26483120"]}, {"Citation": "Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M. 2009. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Clin Infect Dis 48:e16-22\u2013e22. doi:10.1086/595710.", "ArticleIdList": ["10.1086/595710", "19093811"]}, {"Citation": "Sundar S, Chakravarty J. 2008. Paromomycin in the treatment of leishmaniasis. Expert Opin Invest Drugs 17:787\u2013794. doi:10.1517/13543784.17.5.787.", "ArticleIdList": ["10.1517/13543784.17.5.787", "18447603"]}, {"Citation": "Mishra J, Dey A, Singh N, Somvanshi R, Singh S. 2013. Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. Indian J Med Res 137:767\u2013776.", "ArticleIdList": ["PMC3724259", "23703346"]}, {"Citation": "Ribeiro TG, Franca JR, Fuscaldi LL, Santos ML, Duarte MC, Lage PS, Martins VT, Costa LE, Fernandes SO, Cardoso VN, Castilho RO, Soto M, Tavares CA, Faraco AA, Coelho EA, Chavez-Fumagalli MA. 2014. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis. Int J Nanomedicine (Lond) 9:5341\u20135353. doi:10.2147/IJN.S68966.", "ArticleIdList": ["10.2147/IJN.S68966", "PMC4242406", "25429219"]}, {"Citation": "Sundar S, Chakravarty J. 2013. Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother 14:53\u201363. doi:10.1517/14656566.2013.755515.", "ArticleIdList": ["10.1517/14656566.2013.755515", "23256501"]}, {"Citation": "Hughes JP, Rees S, Kalindjian SB, Philpott KL. 2011. Principles of early drug discovery. Br J Pharmacol 162:1239\u20131249. doi:10.1111/j.1476-5381.2010.01127.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.01127.x", "PMC3058157", "21091654"]}, {"Citation": "Uliana SRB, Trinconi CT, Coelho AC. 2018. Chemotherapy of leishmaniasis: present challenges. Parasitology 145:464\u2013480. doi:10.1017/S0031182016002523.", "ArticleIdList": ["10.1017/S0031182016002523", "28103966"]}, {"Citation": "Pastor J, Garcia M, Steinbauer S, Setzer WN, Scull R, Gille L, Monzote L. 2015. Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania. Acta Trop 145:31\u201338. doi:10.1016/j.actatropica.2015.02.002.", "ArticleIdList": ["10.1016/j.actatropica.2015.02.002", "25697866"]}, {"Citation": "Pink R, Hudson A, Mouries MA, Bendig M. 2005. Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 4:727\u2013740. doi:10.1038/nrd1824.", "ArticleIdList": ["10.1038/nrd1824", "16138106"]}, {"Citation": "Lage LM, Barichello JM, Lage DP, Mendonca DV, Carvalho AM, Rodrigues MR, Menezes-Souza D, Roatt BM, Alves RJ, Tavares CA, Coelho EA, Duarte MC. 2016. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis. Parasitol Res 115:4083\u20134095. doi:10.1007/s00436-016-5181-4.", "ArticleIdList": ["10.1007/s00436-016-5181-4", "27365053"]}, {"Citation": "Valadares DG, Duarte MC, Ramirez L, Chavez-Fumagalli MA, Lage PS, Martins VT, Costa LE, Ribeiro TG, Regis WC, Soto M, Fernandes AP, Tavares CA, Coelho EA. 2012. Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis. Parasitol Res 111:1807\u20131816. doi:10.1007/s00436-012-3028-1.", "ArticleIdList": ["10.1007/s00436-012-3028-1", "22797606"]}, {"Citation": "Figueiredo KA, Medeiros SC, Neves JK, da Silva JA, da Rocha Tome A, Carvalho AL, de Freitas RM. 2015. In vivo evaluation of anticonvulsant and antioxidant effects of phenobarbital microemulsion for transdermal administration in pilocarpine seizure rat model. Pharmacol Biochem Behav 131:6\u201312. doi:10.1016/j.pbb.2015.01.008.", "ArticleIdList": ["10.1016/j.pbb.2015.01.008", "25620677"]}, {"Citation": "Pinheiro IM, Carvalho IP, de Carvalho CE, Brito LM, da Silva AB, Conde Junior AM, de Carvalho FA, Carvalho AL. 2016. Evaluation of the in vivo leishmanicidal activity of amphotericin B emulgel: an alternative for the treatment of skin leishmaniasis. Exp Parasitol 164:49\u201355. doi:10.1016/j.exppara.2016.02.010.", "ArticleIdList": ["10.1016/j.exppara.2016.02.010", "26902606"]}, {"Citation": "Xu C, Yu Y, Ling L, Wang Y, Zhang J, Li Y, Duan G. 2017. A C8-modified graphene@mSiO2 composites based method for quantification of gallic acid in rat plasma after oral administration of changtai granule and its application to pharmacokinetics. Biol Pharm Bull 40:1021\u20131028. doi:10.1248/bpb.b17-00015.", "ArticleIdList": ["10.1248/bpb.b17-00015", "28674245"]}, {"Citation": "Mendonca DVC, Martins VT, Lage DP, Dias DS, Ribeiro PAF, Carvalho A, Dias ALT, Miyazaki CK, Menezes-Souza D, Roatt BM, Tavares CAP, Barichello JM, Duarte MC, Coelho EAF. 2018. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. Exp Parasitol 186:24\u201335. doi:10.1016/j.exppara.2018.02.003.", "ArticleIdList": ["10.1016/j.exppara.2018.02.003", "29448040"]}, {"Citation": "Ur-Rehman T, Tavelin S, Grobner G. 2011. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Int J Pharm 409:19\u201329. doi:10.1016/j.ijpharm.2011.02.017.", "ArticleIdList": ["10.1016/j.ijpharm.2011.02.017", "21335076"]}, {"Citation": "van Hemelrijck C, Muller-Goymann CC. 2012. Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy. Int J Pharm 437:120\u2013129. doi:10.1016/j.ijpharm.2012.07.048.", "ArticleIdList": ["10.1016/j.ijpharm.2012.07.048", "22898092"]}, {"Citation": "Islamuddin M, Chouhan G, Farooque A, Dwarakanath BS, Sahal D, Afrin F. 2015. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis. PLoS Negl Trop Dis 9:e3321. doi:10.1371/journal.pntd.0003321.", "ArticleIdList": ["10.1371/journal.pntd.0003321", "PMC4287499", "25568967"]}, {"Citation": "Castro RA, Silva-Barcellos NM, Licio CS, Souza JB, Souza-Testasicca MC, Ferreira FM, Batista MA, Silveira-Lemos D, Moura SL, Frezard F, Rezende SA. 2014. Association of liposome-encapsulated trivalent antimonial with ascorbic acid: an effective and safe strategy in the treatment of experimental visceral leishmaniasis. PLoS One 9:e104055. doi:10.1371/journal.pone.0104055.", "ArticleIdList": ["10.1371/journal.pone.0104055", "PMC4126701", "25105501"]}, {"Citation": "Gill J, Malin M, Sutherland J, Gray D, Hollander G, Boyd R. 2003. Thymic generation and regeneration. Immunol Rev 195:28\u201350. doi:10.1034/j.1600-065x.2003.00077.x.", "ArticleIdList": ["10.1034/j.1600-065x.2003.00077.x", "12969308"]}, {"Citation": "Klein L, Hinterberger M, Wirnsberger G, Kyewski B. 2009. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol 9:833\u2013844. doi:10.1038/nri2669.", "ArticleIdList": ["10.1038/nri2669", "19935803"]}, {"Citation": "Rodrigues KA, Amorim LV, Dias CN, Moraes DF, Carneiro SM, Carvalho FA. 2015. Syzygium cumini (L.) Skeels essential oil and its major constituent alpha-pinene exhibit anti-Leishmania activity through immunomodulation in vitro. J Ethnopharmacol 160:32\u201340. doi:10.1016/j.jep.2014.11.024.", "ArticleIdList": ["10.1016/j.jep.2014.11.024", "25460590"]}, {"Citation": "Klimp AH, de Vries EG, Scherphof GL, Daemen T. 2002. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44:143\u2013161. doi:10.1016/s1040-8428(01)00203-7.", "ArticleIdList": ["10.1016/s1040-8428(01)00203-7", "12413632"]}, {"Citation": "Peters JH, Gieseler R, Thiele B, Steinbach F. 1996. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 17:273\u2013278. doi:10.1016/0167-5699(96)80544-5.", "ArticleIdList": ["10.1016/0167-5699(96)80544-5", "8962630"]}, {"Citation": "Cleary JA, Kelly GE, Husband AJ. 1999. The effect of molecular weight and beta-1,6-linkages on priming of macrophage function in mice by (1,3)-beta-D-glucan. Immunol Cell Biol 77:395\u2013403. doi:10.1046/j.1440-1711.1999.00848.x.", "ArticleIdList": ["10.1046/j.1440-1711.1999.00848.x", "10540205"]}, {"Citation": "Niedergang F, Chavrier P. 2004. Signaling and membrane dynamics during phagocytosis: many roads lead to the phagos(R)ome. Curr Opin Cell Biol 16:422\u2013428. doi:10.1016/j.ceb.2004.06.006.", "ArticleIdList": ["10.1016/j.ceb.2004.06.006", "15261675"]}, {"Citation": "Greenberg S, Grinstein S. 2002. Phagocytosis and innate immunity. Curr Opin Immunol 14:136\u2013145. doi:10.1016/s0952-7915(01)00309-0.", "ArticleIdList": ["10.1016/s0952-7915(01)00309-0", "11790544"]}, {"Citation": "Lee WL, Harrison RE, Grinstein S. 2003. Phagocytosis by neutrophils. Microbes Infect 5:1299\u20131306. doi:10.1016/j.micinf.2003.09.014.", "ArticleIdList": ["10.1016/j.micinf.2003.09.014", "14613773"]}, {"Citation": "Bogdan C, Rollinghoff M. 1998. The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 28:121\u2013134. doi:10.1016/s0020-7519(97)00169-0.", "ArticleIdList": ["10.1016/s0020-7519(97)00169-0", "9504340"]}, {"Citation": "Valadares DG, Duarte MC, Oliveira JS, Chavez-Fumagalli MA, Martins VT, Costa LE, Leite JP, Santoro MM, Regis WC, Tavares CA, Coelho EA. 2011. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Parasitol Int 60:357\u2013363. doi:10.1016/j.parint.2011.06.001.", "ArticleIdList": ["10.1016/j.parint.2011.06.001", "21723957"]}, {"Citation": "Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 144:4794\u20134797.", "ArticleIdList": ["2351828"]}, {"Citation": "Shad A, Leach JC, Teddy PJ, Cadoux-Hudson TA. 2005. Use of the Solis cage and local autologous bone graft for anterior cervical discectomy and fusion: early technical experience. J Neurosurg Spine 2:116\u2013122. doi:10.3171/spi.2005.2.2.0116.", "ArticleIdList": ["10.3171/spi.2005.2.2.0116", "15739521"]}, {"Citation": "Roatt BM, Aguiar-Soares RD, Coura-Vital W, Ker HG, Moreira N, Vitoriano-Souza J, Giunchetti RC, Carneiro CM, Reis AB. 2014. Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease. Front Immunol 5:272. doi:10.3389/fimmu.2014.00272.", "ArticleIdList": ["10.3389/fimmu.2014.00272", "PMC4055865", "24982655"]}, {"Citation": "Pandey MS, Belgamwar VS, Surana SJ. 2009. Topical delivery of flurbiprofen from pluronic lecithin organogel. Indian J Pharm Sci 71:87\u201390. doi:10.4103/0250-474X.51955.", "ArticleIdList": ["10.4103/0250-474X.51955", "PMC2810062", "20177469"]}, {"Citation": "Rabito MF, Britta EA, Pelegrini BL, Scariot DB, Almeida MB, Nixdorf SL, Nakamura CV, Ferreira IC. 2014. In vitro and in vivo antileishmania activity of sesquiterpene lactone-rich dichloromethane fraction obtained from Tanacetum parthenium (L.) Schultz-Bip. Exp Parasitol 143:18\u201323. doi:10.1016/j.exppara.2014.04.014.", "ArticleIdList": ["10.1016/j.exppara.2014.04.014", "24810433"]}, {"Citation": "Grando FC, Felicio CA, Twardowschy A, Paula FM, Batista VG, Fernandes LC, Curi R, Nishiyama A. 2009. Modulation of peritoneal macrophage activity by the saturation state of the fatty acid moiety of phosphatidylcholine. Braz J Med Biol Res 42:599\u2013605. doi:10.1590/s0100-879x2009005000003.", "ArticleIdList": ["10.1590/s0100-879x2009005000003", "19466285"]}, {"Citation": "Bonatto SJ, Folador A, Aikawa J, Yamazaki RK, Pizatto N, Oliveira HH, Vecchi R, Curi R, Calder PC, Fernandes LC. 2004. Lifelong exposure to dietary fish oil alters macrophage responses in Walker 256 tumor-bearing rats. Cell Immunol 231:56\u201362. doi:10.1016/j.cellimm.2004.12.001.", "ArticleIdList": ["10.1016/j.cellimm.2004.12.001", "15919370"]}, {"Citation": "Soares DC, Pereira CG, Meireles MA, Saraiva EM. 2007. Leishmanicidal activity of a supercritical fluid fraction obtained from Tabernaemontana catharinensis. Parasitol Int 56:135\u2013139. doi:10.1016/j.parint.2007.01.004.", "ArticleIdList": ["10.1016/j.parint.2007.01.004", "17306614"]}, {"Citation": "Goncalves JC, Silveira AL, de Souza HD, Nery AA, Prado VF, Prado MA, Ulrich H, Araujo DA. 2013. The monoterpene (-)-carvone: a novel agonist of TRPV1 channels. Cytometry 83A:212\u2013219. doi:10.1002/cyto.a.22236.", "ArticleIdList": ["10.1002/cyto.a.22236", "23307583"]}, {"Citation": "Carneiro SM, Carvalho FA, Santana LC, Sousa AP, Neto JM, Chaves MH. 2012. The cytotoxic and antileishmanial activity of extracts and fractions of leaves and fruits of Azadirachta indica (A Juss.). Biol Res 45:111\u2013116. doi:10.4067/S0716-97602012000200002.", "ArticleIdList": ["10.4067/S0716-97602012000200002", "23096354"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "24"}, {"Year": "2020", "Month": "9", "Day": "6"}, {"Year": "2020", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "15", "Hour": "5", "Minute": "40"}, {"Year": "2021", "Month": "5", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["32928735", "PMC7674045", "10.1128/AAC.00807-20", "AAC.00807-20"]}}]}